{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "f99fc674",
   "metadata": {},
   "outputs": [],
   "source": [
    "# This file contains example of multi-research agents built using parallel workflows\n",
    "# This workflow is used to execute tasks that are independent of each other, it is used for concurrent execution\n",
    "# Importing libraries\n",
    "import os\n",
    "from dotenv import load_dotenv\n",
    "from google.adk.agents import Agent, ParallelAgent, SequentialAgent\n",
    "from google.genai import types\n",
    "from google.adk.models.google_llm import Gemini\n",
    "from google.adk.tools import google_search\n",
    "from google.adk.runners import InMemoryRunner\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "397a67c1",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "API KEY FOUND\n"
     ]
    }
   ],
   "source": [
    "# Check configuration\n",
    "load_dotenv()\n",
    "google_api_key = os.getenv(\"GOOGLE_API_KEY\")\n",
    "if google_api_key:\n",
    "    print(\"API KEY FOUND\")\n",
    "else: \n",
    "    print(\"CONFIGURATION ERROR\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "2ad6d085",
   "metadata": {},
   "outputs": [],
   "source": [
    "def create_retry_config():\n",
    "    '''This functions creates retry configuration'''\n",
    "    return types.HttpRetryOptions(\n",
    "        attempts=7,\n",
    "        exp_base=2, # Used to trigger exponential backoff with 2^n\n",
    "        initial_delay=2, # Initial delay of 2 secs before generating the response\n",
    "        http_status_codes=[429, 500, 502, 503, 504]\n",
    "    )\n",
    "\n",
    "retry_config = create_retry_config()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "baac3632",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "tech_resercher agent created\n"
     ]
    }
   ],
   "source": [
    "# This is a multi-agent system that consists of 4 agents\n",
    "# Tech researcher: The goal of this agent is to focus in AI/ML trends\n",
    "tech_researcher=Agent(\n",
    "    name=\"TechResearcher\",\n",
    "    model=Gemini(\n",
    "        model=\"gemini-2.5-flash-lite\",\n",
    "        retry_options=retry_config\n",
    "    ),\n",
    "    instruction='''Research the latest AI/ML trends. Include 3 key devlopments,\n",
    "    the main companies involved in the research and the potential impact. \n",
    "    Keep the report concise upto 100 words''',\n",
    "    tools=[google_search],\n",
    "    output_key=\"tech_research\"\n",
    ")\n",
    "print(\"tech_resercher agent created\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "704a0fd2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Health researcher created\n"
     ]
    }
   ],
   "source": [
    "# Medical researcher: The goal of this agent is to focus of trends related to medical field\n",
    "health_researcher=Agent(\n",
    "    name=\"HealthResearcher\",\n",
    "    model=Gemini(\n",
    "        model=\"gemini-2.5-flash-lite\",\n",
    "        retry_options=retry_config\n",
    "    ),\n",
    "    instruction='''Research the latest breakthrough in the medical field.\n",
    "    Include recent 3 advancements, their practical use case and estimated timelines''',\n",
    "    tools=[google_search],\n",
    "    output_key=\"health_research\"\n",
    ")\n",
    "print(\"Health researcher created\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "4065b5be",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Finance researcher created\n",
      "<class 'google.adk.agents.llm_agent.LlmAgent'>\n"
     ]
    }
   ],
   "source": [
    "# Finance researcher: The goal is to find latest trends in the fintech world\n",
    "finance_researcher=Agent(\n",
    "    name=\"FinanceResearcher\",\n",
    "    model=Gemini(\n",
    "        model=\"gemini-2.5-flash-lite\",\n",
    "        retry_options=retry_config\n",
    "    ),\n",
    "    instruction='''Research the latest breakthrough in the fintech field.\n",
    "    Include recent 3 discoveries, their practical use case and estimated timelines''',\n",
    "    tools=[google_search],\n",
    "    output_key=\"finance_research\"\n",
    ")\n",
    "print(\"Finance researcher created\")\n",
    "print(type(finance_researcher))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "df1f4c33",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Aggregator agent created\n",
      "<class 'google.adk.agents.llm_agent.LlmAgent'>\n"
     ]
    }
   ],
   "source": [
    "# This agent is used to synthesize the output generated from the other agent, and present it carefully to the user\n",
    "aggregator_agent=Agent(\n",
    "    name=\"AggregatorAgent\",\n",
    "    model=Gemini(\n",
    "        model=\"gemini-2.5-flash-lite\",\n",
    "        retry_options=retry_config\n",
    "    ),\n",
    "    instruction='''Combine the research findings in a single executive memory.\n",
    "    **Technology Trends:**,\n",
    "    {tech_research}\n",
    "\n",
    "    **Health breakthrough:**\n",
    "    {health_research}\n",
    "\n",
    "    **Fintech Innovations:**\n",
    "    {finance_research}\n",
    "\n",
    "    Your summary should highlight common themes, surprising connections and the most important key takeaway''', \n",
    "    output_key=\"executive_summary\"\n",
    ")\n",
    "print(\"Aggregator agent created\")\n",
    "print(type(aggregator_agent))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "b6e48ab6",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Parallel and Sequential agents created\n"
     ]
    }
   ],
   "source": [
    "# Building Parallel agent framework\n",
    "\n",
    "parallel_research_team = ParallelAgent(\n",
    "    name=\"ParallelResearchTeam\",\n",
    "    sub_agents=[tech_researcher, health_researcher, finance_researcher],\n",
    ")\n",
    "\n",
    "root_agent = SequentialAgent(\n",
    "    name=\"ResearchSystem\",\n",
    "    sub_agents=[parallel_research_team, aggregator_agent],\n",
    ")\n",
    "\n",
    "print(\"Parallel and Sequential agents created\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "77eb6b62",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "App name mismatch detected. The runner is configured with app name \"InMemoryRunner\", but the root agent was loaded from \"/Users/arpit/devlopement/agentic-ai-google-kaggle/myvenv/lib/python3.9/site-packages/google/adk/agents\", which implies app name \"agents\".\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " ### Created new session: debug_session_id\n",
      "\n",
      "User > Run the daily executive briefing on Tech, Health, Finance\n",
      "TechResearcher > **Key AI/ML Developments in 2025:**\n",
      "\n",
      "1.  **Generative AI Expansion:** Beyond text and images, Generative AI is now creating novel proteins, materials, and complex multimedia content (video, music). This is revolutionizing scientific discovery and industrial applications.\n",
      "2.  **Agentic AI and Autonomous Systems:** AI systems are gaining the ability to act autonomously, perceive, reason, and make decisions with minimal human input, transforming fields like healthcare, logistics, and finance.\n",
      "3.  **Explainable AI (XAI) and Ethical Frameworks:** As AI becomes more integrated into critical sectors, there's a growing emphasis on XAI to understand AI decision-making, ensure fairness, and build trust.\n",
      "\n",
      "**Main Companies Involved:** OpenAI, Google (DeepMind), Microsoft, NVIDIA, Anthropic, Amazon (AWS), Meta, IBM, Apple, and Databricks are leading research and development.\n",
      "\n",
      "**Potential Impact:** These advancements promise accelerated drug discovery, hyper-automation across industries, more personalized experiences in healthcare and finance, enhanced cybersecurity, and more efficient software development. However, they also raise ethical considerations and necessitate robust governance frameworks.\n",
      "HealthResearcher > ## Health Sector Executive Briefing: Top 3 Medical Breakthroughs\n",
      "\n",
      "This briefing highlights three significant recent advancements in the medical field, their practical applications, and estimated timelines for broader adoption.\n",
      "\n",
      "### 1. Artificial Intelligence (AI) in Diagnostics and Personalized Medicine\n",
      "\n",
      "**Advancement:** AI algorithms are demonstrating remarkable proficiency in analyzing medical imaging (like CT scans and MRIs) and genetic data to aid in disease diagnosis and the development of personalized treatment plans. Google's AI, for example, has shown a greater ability to detect lung cancer than human radiologists. Furthermore, AI is being integrated to predict immunotherapy effectiveness and to tailor therapies to an individual's unique genetic makeup.\n",
      "\n",
      "**Practical Use Case:** AI can significantly improve the speed and accuracy of diagnoses, leading to earlier intervention and better patient outcomes. In personalized medicine, AI can analyze a patient's genetic profile, lifestyle, and environmental factors to recommend the most effective treatments with minimal side effects. This is particularly impactful in oncology, where AI helps tailor treatments to specific tumor profiles. AI-powered remote patient monitoring is also becoming a highly effective technique for managing chronic diseases.\n",
      "\n",
      "**Estimated Timeline:** While AI is already being used in some clinical practices, more extensive use is anticipated within the next 5-10 years. Widespread adoption for advanced diagnostics and personalized treatment recommendations is likely within the next decade, with AI-augmented healthcare systems becoming the norm.\n",
      "\n",
      "### 2. Advancements in Gene Editing Technologies (CRISPR-Cas9 and beyond)\n",
      "\n",
      "**Advancement:** Gene editing technologies, most notably CRISPR-Cas9, have revolutionized the ability to precisely modify DNA. Recent advancements include prime editing and base editing, which offer even greater accuracy and reduced off-target effects. These tools are enabling researchers to target a broader range of diseases with unprecedented precision.\n",
      "\n",
      "**Practical Use Case:** Gene editing holds immense promise for treating genetic disorders at their root cause. Clinical trials are already underway for conditions like sickle cell disease, beta-thalassemia, and certain cancers. A novel regulatory pathway is being explored by the FDA to accelerate the approval of custom gene editing therapies for rare genetic disorders. This technology is also being used to explore treatments for diseases like Alzheimer's and to uncover new therapeutic targets.\n",
      "\n",
      "**Estimated Timeline:** While some gene therapies have already been approved (e.g., for beta-thalassemia and sickle cell disease), many are still in clinical trial phases. Significant expansion of approved gene therapies for a wider array of genetic and acquired diseases is expected within the next 5-10 years, with ongoing refinement of the technology leading to even more precise and safer applications.\n",
      "\n",
      "### 3. Precision Medicine and its Growing Applications\n",
      "\n",
      "**Advancement:** Precision medicine, or personalized medicine, moves away from a \"one-size-fits-all\" approach to healthcare. It tailors disease prevention and treatment based on individual differences in genes, environment, and lifestyle. Advances in next-generation sequencing (NGS) are crucial for identifying genetic variations that guide diagnosis and treatment. Pharmacoexomics, which studies how environmental exposures influence drug response, is further enhancing personalized treatment.\n",
      "\n",
      "**Practical Use Case:** This approach is already leading to powerful new discoveries and FDA-approved treatments tailored to specific genetic profiles, particularly in cancer treatment. Patients with various cancers routinely undergo molecular testing to select treatments that improve survival chances and reduce adverse effects. Precision medicine is also being developed for infectious diseases, neurological disorders, and autoimmune diseases, utilizing techniques like blood transcriptomics and metabolomics for greater accuracy. Researchers are even identifying microbial signatures linked to certain cancers for early detection.\n",
      "\n",
      "**Estimated Timeline:** Precision medicine is already a significant part of current patient care, especially in oncology. Continued expansion and integration into other disease areas are expected over the next 5 years. The development of more sophisticated diagnostic tools and a deeper understanding of the interplay between genetics, environment, and lifestyle will further accelerate its application. Full realization of a truly precision-based healthcare system will likely take more than a decade, but substantial progress will be made in the interim.\n",
      "FinanceResearcher > ## Executive Briefing: Technology, Health, and Finance\n",
      "\n",
      "Here's a summary of recent breakthroughs and their implications across technology, health, and finance, with estimated timelines for broader adoption.\n",
      "\n",
      "### Technology Breakthroughs\n",
      "\n",
      "**1. Generative AI's Advanced Applications**\n",
      "\n",
      "*   **Discovery:** Generative AI (GenAI) is rapidly moving beyond content creation to more sophisticated applications. In finance, it's being used for advanced financial analysis, predictive insights, and automating complex tasks like financial reporting and risk assessment. In healthcare, GenAI is revolutionizing drug discovery by accelerating target identification, molecule design, and predicting drug properties, with some AI-designed drugs already in clinical trials.\n",
      "*   **Use Case:**\n",
      "    *   **Finance:** Generating personalized financial advice, automating report creation, and improving fraud detection through sophisticated pattern analysis.\n",
      "    *   **Health:** Discovering new drug candidates, predicting protein structures, and simulating drug interactions with the human body, significantly reducing development time and cost.\n",
      "*   **Estimated Timeline:**\n",
      "    *   **Finance:** Already in use, with significant expansion expected within the next 1-3 years as more organizations adopt and refine these applications.\n",
      "    *   **Health:** AI-designed drugs are entering clinical trials, with broader application and impact on drug availability anticipated within the next 3-7 years.\n",
      "\n",
      "**2. Quantum Computing's Growing Influence**\n",
      "\n",
      "*   **Discovery:** Quantum computing, once a theoretical concept, is making tangible progress towards real-world applications. In finance, it poses a significant threat to current encryption methods but also offers solutions for enhanced security and faster financial modeling. In technology development, it's being explored for complex problem-solving in areas like cryptography and material science.\n",
      "*   **Use Case:**\n",
      "    *   **Finance:** Developing quantum-resistant cryptography to secure financial transactions, accelerating risk analysis and fraud prevention, and enabling more sophisticated algorithmic trading.\n",
      "    *   **Technology:** Solving complex computational problems previously intractable for classical computers, potentially impacting fields like drug discovery (e.g., modeling molecular interactions) and materials science.\n",
      "*   **Estimated Timeline:**\n",
      "    *   **Finance/Technology:** Early-stage development and research are ongoing. Practical, widespread adoption for critical applications like cryptography is likely 5-10 years away, with initial impacts seen in specialized research and development in the next 2-5 years.\n",
      "\n",
      "**3. Advancements in Gene Editing Technologies (CRISPR)**\n",
      "\n",
      "*   **Discovery:** Gene editing technologies, particularly CRISPR, are becoming more precise and efficient. New retron-based approaches can correct multiple disease-causing mutations simultaneously, offering greater inclusivity for patients with complex genetic disorders. Efforts are also underway to improve control over CRISPR systems, reducing off-target effects and enhancing clinical safety.\n",
      "*   **Use Case:**\n",
      "    *   **Health:** Developing more effective and inclusive gene therapies for a wider range of genetic diseases, including cystic fibrosis and blood disorders like sickle cell disease.\n",
      "    *   **Research:** Creating more accurate disease models for studying genetic interactions and immunological responses.\n",
      "*   **Estimated Timeline:**\n",
      "    *   **Health/Research:** While some CRISPR-based therapies are gaining regulatory approval, widespread clinical application and the development of multi-mutation correction therapies are expected over the next 5-10 years.\n",
      "\n",
      "### Health Breakthroughs\n",
      "\n",
      "**1. Generative AI in Drug Discovery (as detailed in Technology)**\n",
      "\n",
      "*   **Discovery:** As mentioned above, generative AI is a major breakthrough in healthcare, significantly accelerating the drug discovery pipeline.\n",
      "*   **Use Case:** Identifying new drug targets, designing novel drug molecules, predicting efficacy and toxicity, and optimizing clinical trials.\n",
      "*   **Estimated Timeline:** Early AI-discovered drugs are in clinical trials, with broader impact on drug development timelines and costs anticipated within 3-7 years.\n",
      "\n",
      "**2. Advanced Gene Editing (as detailed in Technology)**\n",
      "\n",
      "*   **Discovery:** The development of more precise and efficient gene editing tools, like retron-based systems, is a significant advancement for treating genetic diseases.\n",
      "*   **Use Case:** Enabling gene therapies for a wider array of genetic disorders by correcting multiple mutations simultaneously and reducing unintended side effects.\n",
      "*   **Estimated Timeline:** While initial therapies are emerging, widespread adoption and the development of more complex gene editing treatments are expected within 5-10 years.\n",
      "\n",
      "**3. AI Agents and Personalized Healthcare**\n",
      "\n",
      "*   **Discovery:** AI agents are evolving from basic chatbots to autonomous systems capable of performing complex, multi-step tasks and interacting with third parties. This is leading to more personalized and proactive healthcare management.\n",
      "*   **Use Case:**\n",
      "    *   **Patient Journey Management:** AI agents can assist in triaging symptoms, scheduling tests, analyzing results, and managing follow-up care, creating a more seamless patient experience.\n",
      "    *   **Remote Patient Monitoring:** AI-powered wearables and connected devices provide continuous health data, enabling early detection of health issues and proactive interventions.\n",
      "    *   **Personalized Medicine:** AI helps in tailoring treatments and lifestyle recommendations based on individual health data and predispositions.\n",
      "*   **Estimated Timeline:** AI agents are already being piloted, with broader integration into healthcare systems and patient management expected within the next 2-5 years. Wearable technology for remote monitoring is already prevalent and will continue to expand its capabilities within 1-3 years.\n",
      "\n",
      "### Finance Breakthroughs\n",
      "\n",
      "**1. Generative AI for Enhanced Financial Operations (as detailed in Technology)**\n",
      "\n",
      "*   **Discovery:** Generative AI is being deployed for sophisticated financial tasks, from predictive analytics and algorithmic trading to customer service and fraud detection.\n",
      "*   **Use Case:** Automating complex financial reporting, providing personalized financial advice, optimizing investment portfolios, and significantly improving fraud detection accuracy.\n",
      "*   **Estimated Timeline:** Already in active use, with increased adoption and refinement expected over the next 1-3 years.\n",
      "\n",
      "**2. Quantum Computing's Dual Impact on Security (as detailed in Technology)**\n",
      "\n",
      "*   **Discovery:** Quantum computing presents a paradigm shift for fintech security, threatening current encryption but also offering pathways to quantum-resistant security solutions.\n",
      "*   **Use Case:** Developing quantum-safe encryption to protect financial data from future quantum attacks and leveraging quantum's processing power for advanced risk analysis and fraud detection.\n",
      "*   **Estimated Timeline:** Development of quantum-resistant cryptography is a critical ongoing effort, with initial implementations and widespread adoption expected in 5-10 years. Early applications in specialized risk analysis may appear sooner (2-5 years).\n",
      "\n",
      "**3. Regulatory Technology (RegTech) for Smarter Compliance**\n",
      "\n",
      "*   **Discovery:** RegTech continues to evolve, integrating AI, machine learning, and blockchain to automate and streamline regulatory compliance processes for financial institutions.\n",
      "*   **Use Case:** Automating compliance checks, improving financial reporting accuracy, enhancing fraud detection, and enabling real-time monitoring of regulatory changes, thereby reducing costs and mitigating risks.\n",
      "*   **Estimated Timeline:** RegTech is already widely adopted, with continuous advancements and deeper integration expected over the next 1-3 years as regulations become more complex and data-driven oversight increases.\n",
      "AggregatorAgent > ## Executive Summary: Convergence of AI, Gene Editing, and Quantum Computing Driving Transformative Change\n",
      "\n",
      "This briefing synthesizes key recent developments in technology, health, and finance, highlighting a powerful synergy driven by advancements in **Artificial Intelligence (AI)**, particularly **Generative AI** and **Agentic AI**, alongside groundbreaking progress in **Gene Editing** and the emerging potential of **Quantum Computing**.\n",
      "\n",
      "**Common Themes & Surprising Connections:**\n",
      "\n",
      "*   **AI as the Unifying Force:** AI, especially Generative AI, is the most pervasive theme, acting as a catalyst across all sectors. It's revolutionizing scientific discovery (proteins, materials), enabling personalized medicine and diagnostics, and automating complex financial operations and compliance. Agentic AI further amplifies this by bringing autonomous decision-making to healthcare management and financial analysis.\n",
      "*   **Precision and Personalization:** Both health and finance are moving towards hyper-personalization. In health, this is seen in AI-driven diagnostics and precision medicine tailored to individual genetics and lifestyles. In finance, it's manifesting in personalized financial advice and tailored risk assessments.\n",
      "*   **Data-Intensive Innovation:** All breakthroughs rely heavily on massive datasets. AI models learn from them, gene editing research is informed by genomic data, and quantum computing's potential is unlocked through complex data modeling.\n",
      "*   **Future-Proofing and Security:** Quantum computing, while posing a threat to current financial encryption, is also driving the development of quantum-resistant security, highlighting a critical need for proactive cybersecurity measures across all data-sensitive industries.\n",
      "*   **Accelerated Timelines:** The rapid evolution of AI is compressing development and adoption timelines. While some AI applications are already in use, significant expansion is expected within 1-3 years, with even more profound impacts anticipated in the 3-7 year and 5-10 year horizons across all sectors.\n",
      "\n",
      "**Most Important Key Takeaway:**\n",
      "\n",
      "The most critical takeaway is the **accelerated convergence of AI, advanced biotechnology (gene editing), and computing power (quantum)**. These forces are not developing in isolation but are increasingly interconnected, creating a feedback loop of innovation. Generative AI is not only accelerating drug discovery and personalized medicine but is also instrumental in developing more precise gene editing tools. In parallel, the computational demands of these fields are driving the exploration of quantum computing. This convergence promises unprecedented breakthroughs in human health and economic efficiency, but it simultaneously elevates the importance of robust ethical frameworks, explainable AI (XAI), and proactive governance to manage the profound societal implications.\n"
     ]
    }
   ],
   "source": [
    "runner = InMemoryRunner(agent=root_agent)\n",
    "response = await runner.run_debug(\n",
    "    \"Run the daily executive briefing on Tech, Health, Finance\"\n",
    ")"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "myvenv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
